| Variable | Sample Size | Mean (SD), Range | N (%) |
| General Information | |||
| Age | 51 | 60.2 (7.1), 45 - 73 |
|
| Education | 51 | 15.8 (3.4), 8 - 23 |
|
| Ethnicity | 52 |
|
|
| Caucasian |
|
| 36 (69.8) |
| African-American |
|
| 16 (30.2) |
| Marital status | 51 |
|
|
| Married/partnered |
|
| 42 (82.4) |
| Single/widowed |
|
| 9 (17.6) |
| Monthly family income | 48 |
|
|
| $500 - 1000 |
|
| 5 (10.4) |
| $1001 - 2000 |
|
| 5 (10.4) |
| $2001 - 4000 |
|
| 11 (22.9) |
| > $4000 |
|
| 27 (56.3) |
| Full-time working status, Yes | 48 |
| 38 (79.2) |
| Health insurance coverage, Yes | 51 |
| 50 (94.3) |
| Decision-related Information* |
|
|
|
| Decision-made before visit, Yes | 50 |
| 16 (32.0) |
| Recommended treatment, Yes | 48 |
| 38 (79.2) |
| Decision-made when left, Yes | 49 |
| 24 (49.0) |
| Additional time for decision, Yes | 48 |
| 31 (64.6) |
| Disease-related Information |
|
|
|
| Gleason Score | 46 | 6.37 (0.61), 5 - 8 |
|
| ≤6 |
|
| 28 (60.9) |
| =7 |
|
| 17 (37.0) |
| ≥8 |
|
| 1 (2.2) |
| Prostate Specific Antigen | 48 | 8.00 (7.19), 3 - 40 |
|
| Cancer risk level | 52 |
|
|
| Low |
|
| 34 (64%) |
| Intermediate |
|
| 17 (32%) |
| High |
|
| 1 (4%) |